P. Diner and K. A. Jørgensen, J. Am. Chem. Soc., 2006, 128,
12973; (c) S. Kobbelgaard, S. Brandes and K. A. Jørgensen,
Chem.–Eur. J., 2008, 14, 1464; (d) C. Cassani, L. Bernadi,
F. Fini and A. Ricci, Angew. Chem., Int. Ed., 2009, 48, 5694;
(e) G. Ma, S. Cao and M. Shi, Tetrahedron: Asymmetry, 2009, 20,
1086; (f) T. Zhang, L. Dai and X. Hou, Tetrahedron: Asymmetry,
2007, 18, 1990; (g) Z. Wang, X. Ye, S. Wei, P. Wu, A. Zang and
J. Sun, Org. Lett., 2006, 8, 999.
4 For recent reviews see: (a) M. M. B. Marques, Angew. Chem., Int.
Ed., 2006, 45, 348; (b) A. Ting and S. E. Schaus, Eur. J. Org.
Chem., 2007, 5797; (c) J. M. M. Verkade, L. J. C. van Hemert,
P. J. L. M. Quaedflieg and F. P. J. T. Rutjes, Chem. Soc. Rev.,
2008, 37, 29; For selected recent examples see: (d) M. Terada,
K. Machioka and K. Sorimachi, Angew. Chem., Int. Ed., 2006, 45,
2254; (e) N. S. Chowdari, M. Ahmad, K. Albertshofer, F. Tanaka
and C. F. Barbas III, Org. Lett., 2006, 8, 2839; (f) A. L. Tillman
and D. J. Dixon, Org. Biomol. Chem., 2007, 5, 606; (g) M. Rueping,
E. Sugiono and F. Schoepke, Synlett, 2007, 1441; (h) D. Uraguchi,
Y. Ueki and T. Ooi, J. Am. Chem. Soc, 2008, 130, 14088;
(i) J. W. Yang, C. Chandler, M. Stadler, D. Kampen and
B. List, Nature, 2008, 452, 453; (j) H. Yang and R. G. Carter,
J. Org. Chem., 2009, 74, 2246; (k) P. Dziedzic, P. Schyman,
M. Kullberg and A. Cordova, Chem.–Eur. J., 2009, 15, 4044.
5 M. Nielsen, C. B. Jacobsen, M. W. Paixao, N. Holub and
K. A. Jørgensen, J. Am. Chem. Soc., 2009, 131, 10581.
Scheme 2 Transformation of intermediate 3 into optically active
b-keto amino compounds 5.
products 5d–f were obtained in good to excellent yields and
enantiomeric excess. Moreover, both desulfonylation methods
presented here represent, to the best of our knowledge, the first
reactions of this type performed in an organomediated manner.10
The absolute configurations of the products 4 and 5 were
correlated to the absolute configuration of 5b, which was
determined to be R by comparison with the literature.11
In conclusion, we have reported a new enantioselective
organocatalytic addition of b-keto benzothiazolesulfones to
N-Boc-protected imines. The resultant key intermediate can
easily be transformed into optically active trans-allylic amines,
absent of a conjugate electron-withdrawing substituent, or
optically active b-keto amino compounds in good yields and
enantioselectivities.
6 C. Aıssa, Eur. J. Org. Chem., 2009, 1831.
7 For recent reviews see e.g.: (a) A. G. Doyle and E. N. Jacobsen,
Chem. Rev., 2007, 107, 5713; (b) Z. Zhang and P. R. Schreiner,
Chem. Soc. Rev., 2009, 38, 1187.
8 For a recent article concerning the synthesis of compounds containing
this moiety see: G. W. Stewart, C. A. Baxter, E. Cleator and
F. J. Sheen, J. Org. Chem., 2009, 74, 3229.
9 For a few recent examples see: As HIV-1 protease inhibitors:
(a) D. L. N. G. Surleraux, H. A. Kock, W. G. Verschueren,
G. M. E. Pille, L. J. R. Maes, A. Peeters, S. Vendeville,
S. D. Meyer, H. Azijn, R. Pauwels, M. Bethune, N. M. King,
M. Prabu-Jeyabalan, C. A. Schiffer and P. B. T. P. Wigerinck,
J. Med. Chem., 2005, 48, 1965; As vanilloid receptor-1 antagonists:
(b) E. M. Doherty, C. Fotsch, A. W. Bannon, Y. Bo, N. Chen,
C. Dominguez, J. Falsey, N. R. Gavva, J. Katon, T. Nixey,
V. I. Ognyanov, L. Pettus, R. M. Rzasa, M. Stec, S. Surapaneni,
R. Tamir, J. Zhu, J. J. S. Treanor and M. H. Norman, J. Med.
Chem., 2007, 50, 3515; As c-Src kinase and nitric oxide synthase
inhibitors: (c) X. Cao, Q. You, Z. Li, Q. Guo, J. Shang, M. Yan,
J. Chernc and M. Chenc, Bioorg. Med. Chem., 2008, 16, 5890; As
CYP26 inhibitors see: (d) M. S. Gomaa, J. L. Armstrong,
B. Bobillon, G. J. Veal, A. Brancale, C. P. F. Redfern and
C. Simons, Bioorg. Med. Chem., 2008, 16, 8301.
This work was made possible by a grant from The Danish
National Research Foundation, OChemSchool and Carlsberg
Foundation. D.M. thanks the ‘‘Ministerio de Ciencia e
Innovacion’’ of Spain for a postdoctoral fellowship.
Notes and references
1 For reviews on allylic amination see e.g.: (a) M. Johannsen and
K. A. Jørgensen, Chem. Rev., 1998, 98, 1689; (b) B. M. Trost and
M. L. Crawley, Chem. Rev., 2003, 103, 2921.
2 For recent examples see e.g.: (a) S. Lou and S. E. Schaus, J. Am.
Chem. Soc., 2008, 130, 6922; (b) J. A. Bishop, S. Lou and
S. E. Schaus, Angew. Chem., Int. Ed., 2009, 48, 4337; (c) K. Brak
and J. A. Ellman, J. Am. Chem. Soc., 2009, 131, 3850.
10 For a review on desulfonylation reactions see: C. Najera and
M. Yus, Tetrahedron, 1999, 55, 10547.
11 The absolute configuration was determined to be R by comparison
of the specific rotation of 5b with the literature: A. L. Tillman and
D. J. Dixon, Org. Biomol. Chem., 2007, 5, 606.
3 (a) T. B. Poulsen, C. Alemparte and K. A. Jørgensen, J. Am. Chem.
Soc., 2005, 127, 11614; (b) S. Bertelsen, M. Marigo, S. Brandes,
ꢀc
This journal is The Royal Society of Chemistry 2009
6556 | Chem. Commun., 2009, 6554–6556